A novel dietary-related model of esophagitis and Barrett's esophagus, a premalignant lesion

Nutrition and Cancer

Volumn 59, Issue 2, 2007, Pages 217-227

  Guy, Naihsuan C ^a   Garewal, Harinder ^a,b   Holubec, Hana ^a   Bernstein, Harris ^a   Payne, Claire M ^a,b   Bernstein, Carol ^a,b   Bhattacharyya, Achyut K ^a   Dvorak, Katerina ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BILE ACID; DEOXYCHOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN 2; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARRETT ESOPHAGUS; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS MUCOSA; ESOPHAGUS TUMOR; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; WILD TYPE;

MUS;

EID: 36849089128     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701499529     Document Type: Article

References (56)

1. Jankowski JA, Harrison RF, Perry I, Balkwill F, and Tselepis, C: Barrett's metaplasia. Lancet 356, 2079-2085, 2000.
2. Falk GW: Barrett's esophagus. Gastroenterology 122, 1569-1591, 2002.
3. Bonino JA and Sharma P: Barrett's esophagus. Curr Opin Gastroenterol 21, 461-465, 2005.
4. Devesa SS, Blot WJ, and Fraumeni JF Jr.: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83, 2049-2053, 1998.
5. Ozata M, Mergen M, Oktenli C, Ay din A, Sanisoglu SY, et al.: Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 35, 627-631, 2002.
6. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, et al.: Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130, 639-649, 2006.
7. Oh DS, Hagen JA, Fein M, Bremner CG, Dunst CM, et al.: The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg 10, 787-796, 796-797, 2006.
8. Su Y, Chen X, Klein M, Fang M, Wang S, et al.: Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab Invest 84, 753-765, 2004.
9. Prasad AS and Kucuk O: Zinc in cancer prevention. Cancer Metastasis Rev 21, 291-295, 2002.
10. Maret W and Sandstead HH: Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20, 3-18, 2006.
11. Fong LY, Ishii H, Nguyen VT, Vecchione A, Farber JL, et al.: p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. Cancer Res 63, 186-195, 2003.
12. Fong LY, Mancini R, Nakagawa H, Rustgi AK, and Huebner K: Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis. Cancer Res 63, 4244-4252, 2003.
13. Webb JL: Nutritional effects of oral contraceptive use: a review. J Reprod Med 25, 150-156, 1980.
14. Golik A, Zaidenstein R, Dishi V, Blatt A, Cohen N, et al.: Effects of Captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr 17, 75-78, 1998.
15. Ozutemiz AO, Aydin HH, Isler M, Celik HA, and Batur Y: Effect of omeprazole on plasma zinc levels after oral zinc administration. Indian J Gastroenterol 21, 216-218, 2002.
16. Reyes AJ, Olhaberry JV, Leary WP, Lockett CJ, and van der Byl K: Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J 64, 936-941, 1983.
17. Kauer WK, Peters JH, DeMeester TR, Feussner H, Ireland AP, et al.: Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 122, 874-878, 1997.
18. Theisen J, Nehra D, Citron D, Johansson J, Hagen JA, et al.: Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 4, 50-54, 2000.
19. Nehra D, Howell P, Williams CP, Pye JK, and Beynon J: Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44, 598-602, 1999.
20. Kelman Z: PCNA: structure, functions and interactions. Oncogene 14, 629-640, 1997.
21. Li Y, Wo JM, Su RR, Ray MB, Jones W, et al.: Esophageal injury with external esophageal perfusion. J Surg Res 129, 107-113, 2005.
22. Lagergren J, Bergstrom R, Lindgren A, and Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340, 825-831, 1999.
23. Cameron AJ: Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 26, 487-494, 1997.
24. Bernstein H, Bernstein C, Payne CM, Dvorakova K, and Garewal H: Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589, 47-65, 2005.
25. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, et al.: A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 59, 2353-2357, 1999.
26. Dixon MF, Neville PM, Mapstone NP, Moayyedi P, and Axon AT: Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut 49, 359-363, 2001.
27. Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, et al.: Risk factors, DNA damage, and disease progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14, 620-625, 2005.
28. Payne CM, Crowley-Weber CL, Dvorak K, Bernstein C, Bernstein H, et al.: Mitochondrial perturbation attenuates bile acid-induced cytotoxicity. Cell Biol Toxicol 21, 215-231, 2005.
29. Souza RF, Shewmake K, Terada LS, and Spechler SJ: Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 122, 299-307, 2002.
30. Kaur BS and Triadafilopoulos G: Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. Am J Physiol Gastrointest Liver Physiol 283, G327-334, 2002.
31. Duggan SP, Gallagher WM, Fox EJ, Abdel-Latif MM, Reynolds JV, et al.: Low pH induces co-ordinate regulation of gene expression in oesophageal cells. Carcinogenesis 27, 319-327, 2006.
32. Ho E and Ames BN: Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 99, 16770-16775, 2002.
33. Sandstead HH: Understanding zinc: recent observations and interpretations. J Lab Clin Med 124, 322-327, 1994.
34. Chen H, Tucker KL, Graubard BI, Heineman EF, Markin RS, et al.: Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer 42, 33-40, 2002.
35. Steininger H, Pfofe DA, Muller H, Haag-Sunjic G, and Fratianu V: Expression of CDX2 and MUC2 in Barrett's mucosa. Pathol Res Pract 201, 573-577, 2005.
36. Carrato C, Balague C, de Bolos C, Gonzalez E, Gambus G, et al.: Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology 107, 160-172, 1994.
37. Van De Bovenkamp JH, Korteland-Van Male AM, Warson C, Buller HA, Einerhand AW, et al.: Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2. Histopathology 42, 555-565, 2003.
38. Ishizuka I, Andoh A, Koyama S, Moritani S, Kushima R, et al.: Immunohistochemical analysis of short-segment Barrett's esophagus. J Gastroenterol Hepatol 19, 1410-1416, 2004.
39. Dvorak K, Ramsey L, Payne CM, Sampliner R, Fass R, et al.: Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg 244, 1031-1036, 2006.
40. Farhadi A, Fields J, Banan A, and Keshavarzian A: Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol 97, 22-26, 2002.
41. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, et al.: Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med 30, 905-915, 2001.
42. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, et al.: Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 5, 763-771, 2006.
43. Beckman JS: Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9, 836-844, 1996.
44. Bae JD, Jung KH, Ahn WS, Bae SH, and Jang TJ: Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents reflux. J Korean Med Sci 20, 56-60, 2005.
45. Jimenez P, Piazuelo E, Sanchez MT, Ortego J, Soteras F, et al.: Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J Gastroenterol 11, 2697-2703, 2005.
46. Lanas A, Soteras F, Jimenez P, Fiteni I, Piazuelo E, et al.: Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits. Dig Dis Sci 46, 2733-2743, 2001.
47. Konturek PC, Nikiforuk A, Kania J, Raithel M, Hahn EG, et al.: Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig Dis Sci 49, 1075-1083, 2004.
48. Baldwin AS Jr.: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14, 649-683, 1996.
49. Abdel-Latif MM, O'Riordan J, Windle HJ, Carton E, Ravi N, et al.: NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiofherapy. Ann Surg 239, 491-500, 2004.
50. Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, et al.: Beta-catenin expression in human cancers. Am J Pathol 148, 39-46, 1996.
51. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, et al.: Altered Cadherin and catenin complexes in the Barrett's esophagus-dysplasia- adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 152, 135-144, 1998.
52. Kimura Y, Shiozaki H, Doki Y, Yamamoto M, Utsunomiya T, et al.: Cytoplasmic beta-catenin in esophageal cancers. Int J Cancer 84, 174-178, 1999.
53. Bian YS, Osterheld MC, Bosnian FT, Fontolliet C, and Benhattar J: Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. Am J Clin Pathol 114, 583-590, 2000.
54. Osterheld MC, Bian YS, Bosnian FT, Benhattar J, and Fontolliet C: Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. Am J Clin Pathol 117, 451-456, 2002.
55. Jenkins GJ, Harries K, Doak SH, Wilmes A, Griffiths AP, et al.: The bile acid deoxycholic acid (DCA) at neutral pH activates NF-{kappa}B and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis 25, 317-323, 2004.
56. O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, et al.: Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 100, 1257-1264, 2005.